Treatment situation of male hypogonadotropic hypogonadism in pediatrics and proposal of testosterone and gonadotropins replacement therapy protocols-Reference-Cited by-同舟云学术

Treatment situation of male hypogonadotropic hypogonadism in pediatrics and proposal of testosterone and gonadotropins replacement therapy protocols

Published:2015 Issue:2 Volume:24 Page:37-49
ISSN:0918-5739
Container-title:Clinical Pediatric Endocrinology
language:en
Short-container-title:Clin Pediatr Endocrinol

Author:

Sato Naoko¹²,Hasegawa Tomonobu³⁴²,Hasegawa Yukihiro⁵²,Arisaka Osamu⁶⁴,Ozono Keiichi⁷⁴,Amemiya Shin⁸⁴,Kikuchi Toru⁹⁴,Tanaka Hiroyuki⁴²,Harada Shohei¹⁰⁴,Miyata Ichiro¹¹⁴,Tanaka Toshiaki¹⁴²

Affiliation:

1. Tanaka Growth Clinic, Tokyo, Japan

2. Study Group of Treatment for MHH

3. Department of Pediatrics, Keio University Hospital, Tokyo, Japan

4. Pharmaceutical Affairs Committee, the Japanese Society for Pediatric Endocrinology

5. Division of Endocrinology and Metabolism, Tokyo Metropolitan Children’s Medical Center, Tokyo, Japan

6. Department of Pediatrics, Dokkyo Medical University, Tochigi, Japan

7. Department of Pediatrics, Osaka University, Osaka, Japan

8. Department of Pediatrics, Saitama Medical University, Saitama, Japan

9. Department of Pediatrics, Niigata University, Niigata, Japan

10. Division of Clinical Practice Policy, National Institute for Child Health and Development, Tokyo, Japan

11. Department of Pediatrics, Jikei University School of Medicine, Tokyo, Japan

Publisher

Japanese Society for Pediatric Endocrinology

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology, and Child Health

Link

https://www.jstage.jst.go.jp/article/cpe/24/2/24_9995/_pdf

Reference24 articles.

1. 1. Han TS, Bouloux PM. What is the optimal therapy for young males with hypogonadotropic hypogonadism? Clin Endocrinol (Oxf) 2010;72: 731–7.

2. 2. Manual for the diagnosis and treatment of decreased gonadotropin secretion. Investigational research team for functional hypothalamic and pituitary disorders, research on measures for intractable diseases. Health and labor sciences research grant (http://rhhd.info/) (Only in Japanese).

3. 3. Oyama K, Nakagome Y, Kobayashi H, Satoh K, Uchida N, Sano T, et al. Examination of methods for inducing secondary sex characteristics for the treatment of male hypogonadotropic hypogonadism. Jap J Pediatr Soc 2008;112: 1667–73 (Only in Japanese).

4. 4. Rogol AD. New facets of androgen replacement therapy during childhood and adolescence. Expert Opin Pharmacother 2005;6: 1319–36.

5. 5. Nabhan Z, Eugster EA. Hormone replacement therapy in children with hypogonadotropic hypogonadism: where do we stand? Endocr Pract 2013;19: 968–71.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gonadotropins for pubertal induction in males with hypogonadotropic hypogonadism: systematic review and meta-analysis;European Journal of Endocrinology;2023-12-21

2. Puberty induction in boys with congenital isolated hypogonadotropic hypogonadism;Problems of Endocrinology;2023-02-25

3. Evaluating the Combination of Human Chorionic Gonadotropin and Clomiphene Citrate in Treatment of Male Hypogonadotropic Hypogonadism: A Prospective Study;Research and Reports in Urology;2021-06

4. Efficacy and safety of human chorionic gonadotropin combined with human menopausal gonadotropin and a gonadotropin-releasing hormone pump for male adolescents with congenital hypogonadotropic hypogonadism;Chinese Medical Journal;2021-03-31

5. Male hypogonadism: therapeutic choices and pharmacological management;Minerva Endocrinologica;2020-09